10.25384/SAGE.10315556.v1
Marika Cinausero
Marika
Cinausero
Noemi Laprovitera
Noemi
Laprovitera
Giovanna De Maglio
Giovanna De
Maglio
Lorenzo Gerratana
Lorenzo
Gerratana
Mattia Riefolo
Mattia
Riefolo
Marianna Macerelli
Marianna
Macerelli
Michelangelo Fiorentino
Michelangelo
Fiorentino
Elisa Porcellini
Elisa
Porcellini
Vanessa Buoro
Vanessa
Buoro
Francesco Gelsomino
Francesco
Gelsomino
Anna Squadrilli
Anna
Squadrilli
Gianpiero Fasola
Gianpiero
Fasola
Massimo Negrini
Massimo
Negrini
Marcello Tiseo
Marcello
Tiseo
Manuela Ferracin
Manuela
Ferracin
Andrea Ardizzoni
Andrea
Ardizzoni
Supplementary_Figure_1 – Supplemental material for KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC
SAGE Journals
2019
anti-PD-1
immunotherapy
nivolumab
non-small cell lung cancer
pembrolizumab
2019-11-16 13:06:42
Figure
https://sage.figshare.com/articles/figure/Supplementary_Figure_1_Supplemental_material_for_KRAS_and_ERBB-family_genetic_alterations_affect_response_to_PD-1_inhibitors_in_metastatic_nonsquamous_NSCLC/10315556
<p>Supplemental material, Supplementary_Figure_1 for KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC by Marika Cinausero, Noemi Laprovitera, Giovanna De Maglio, Lorenzo Gerratana, Mattia Riefolo, Marianna Macerelli, Michelangelo Fiorentino, Elisa Porcellini, Vanessa Buoro, Francesco Gelsomino, Anna Squadrilli, Gianpiero Fasola, Massimo Negrini, Marcello Tiseo, Manuela Ferracin and Andrea Ardizzoni in Therapeutic Advances in Medical Oncology</p>